These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Differences in the allergic responses between bronchial asthma and rheumatoid arthritis patients to administration of ACTH-preparation]. Muranaka M; Takeda K; Kikutani T; Okumura H; Nishizawa I; Suzuki S; Ito K; Araki H Nihon Naika Gakkai Zasshi; 1965 Jul; 54(4):311-9. PubMed ID: 4284078 [No Abstract] [Full Text] [Related]
23. [Current perspectives in the control of bronchial asthma. Synacthen Depot]. Cardoso R Hospital (Rio J); 1969 Oct; 76(4):1439-54. PubMed ID: 4312092 [No Abstract] [Full Text] [Related]
24. [Ceruloplasmin activity in various clinical forms of bronchial asthma and during ACTH, hydrocortisone, and deseril administration]. Chachaj W; Cieślińska A; Ciosek W Pol Tyg Lek; 1970 Apr; 25(17):598-600. PubMed ID: 4316784 [No Abstract] [Full Text] [Related]
25. Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity. Glass D; Roffe L; Maini RN; Wraith DG; Nuki G Clin Exp Immunol; 1975 Apr; 20(1):55-63. PubMed ID: 173487 [TBL] [Abstract][Full Text] [Related]
26. Assessment of long-acting synthetic corticotrophin in hypersensitive asthmatics and normal subjects. el-Shaboury AH Br Med J; 1968 Sep; 3(5619):653-5. PubMed ID: 4299775 [TBL] [Abstract][Full Text] [Related]
27. Treatment of bronchial asthma with synthetic long-term corticotrophin. Anderson E; Lorenzen J Scand J Respir Dis Suppl; 1970; 72():127. PubMed ID: 4320311 [No Abstract] [Full Text] [Related]
28. [Treatment of bronchial asthma using a synthetic beta 1-18 corticotropin derivative]. Walser A; Keller R; Herzog H Schweiz Med Wochenschr; 1969 Nov; 99(48):1726-8. PubMed ID: 4312242 [No Abstract] [Full Text] [Related]
29. [Depot-ACTH in the ambulatory management of obstructive bronchial diseases]. Frank A Wien Med Wochenschr; 1968 Mar; 118(12):253-6. PubMed ID: 4301963 [No Abstract] [Full Text] [Related]
30. [Synthetic delayed-action ACTH in bronchial asthma]. Szimak J Wien Med Wochenschr; 1971 Feb; 121(6):96-9. PubMed ID: 4322589 [No Abstract] [Full Text] [Related]
31. [Effect of a tetracosactide with depot action in the asthmatic syndrome]. Illig H Med Klin; 1970 May; 65(20):985-7. PubMed ID: 4325139 [No Abstract] [Full Text] [Related]
32. [Hormonal changes and clinical effects produced in patients treated with a delyed-action preparation of synthetic ACTH]. Faglia G; Travanglini P; Norbiato G; Ambrosi B; Gattinoni L Clin Ter; 1968 Jul; 46(1):23-44. PubMed ID: 4302946 [No Abstract] [Full Text] [Related]
33. [Clinical and pharmacologic studies of synthetic ACTH]. Bíró L; Iván E; Sándor P; Perényi T Orv Hetil; 1971 Jun; 112(23):1327-9. PubMed ID: 4327819 [No Abstract] [Full Text] [Related]
34. [Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction]. Kropp R Fortschr Med; 1976 Mar; 94(7):395-8. PubMed ID: 184022 [TBL] [Abstract][Full Text] [Related]
35. [Beta 1-24 corticotrophin or tetracosactide in asthma and allergic diseases]. Wolfromm R; Herman D Therapeutique; 1969 Feb; 45(2):131-46. PubMed ID: 4320666 [No Abstract] [Full Text] [Related]
36. [Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases]. Kawai M; Maekawa N Nihon Kyobu Shikkan Gakkai Zasshi; 1975 Nov; 13(11):663-70. PubMed ID: 176495 [No Abstract] [Full Text] [Related]
37. [Tetracosactid delay in the treatment of bronchial asthma]. Wolfromm R; Herman D Folia Allergol (Roma); 1970; 17(4):396-7. PubMed ID: 4318713 [No Abstract] [Full Text] [Related]